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Nonsurgical Management of the 
Boutonniere Deformity 
Nancy S. Palchik, Douglas M. Mitchell, Naomi L. Gilbert, Amy J. Schulz, 
Robert F. Dedrick, and Thomas D. Palella 
The present study examined the effectiveness of a 
6-week experimental program of splinting and joint 
protection education in reducing the progression of 
the early boutonniere deformity. Nine patients with 
mild or moderately reducible boutonniere deformi- 
ties were randomized into experimental and control 
groups and followed for 1 year. Improvements in 
active extension of the proximal interphalangial 
joint for patients in the experimental program sug- 
gest that early initiation of a nonsurgical interven- 
tion can reduce or reverse progression of the bouton- 
niere deformity in some patients with rheumatoid 
mthritis. Although the number of patients was small, 
we conclude that early splinting and joint protection 
education may limit the anatomical and functional 
(derangements of boutonniere deformity in the rheu- 
matoid hand. 
The boutonniere deformity occurs in 15%-36% of 
id1 rheumatoid arthritis (RA) patients with hand 
~nvolvement [l, 21. Despite its prevalence, there is 
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little information relating the deformity to the history 
or severity of underlying disease and little describing 
clinical factors associated with its progression. Man- 
agement of the boutonniere deformity of rheumatoid 
origin has been almost entirely limited to surgical 
interventions. The deformity has been difficult to 
treat nonsurgically, in part because of the stretching 
of the supporting fibers, which takes place as the 
lateral bands displace [3] (Figure 1). 
Although management of the early boutonniere de- 
formity of traumatic origin has included splinting 
[4-71, there has been little research examining this 
intervention for deformities of rheumatoid origin and 
no controlled studies in either group. However, some 
informal case reports have indicated that splinting 
may be an effective intervention when initiated in 
the early stages of the boutonniere deformity [3,  81, 
and a variety of splinting interventions used to pre- 
vent and manage the deformity of rheumatoid origin 
have been described [9-151. While these reports sug- 
gest that splinting a passively correctable bouton- 
niere deformity has the potential to restore active 
range of motion (ROM), this has not been tested for- 
mally. 
The purpose of this study was to explore the effi- 
cacy of a nonsurgical approach to managing the re- 
ducible boutonniere deformity. The specific objec- 
tive of the study was to obtain preliminary 
information about the progression of the boutonniere 
deformity and the impact of a splinting and educa- 
tional intervention on this progression. 
METHODS 
Obtaining the Patient Sample 
Over a 10-month period, patients attending a univer- 
sity-based arthritis outpatient clinic were screened 
for the boutonniere deformity using a five-item symp- 
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tom checklist completed by clinic physicians. The 
screening instrument recorded the presence or ab- 
sence of arthritis or inflammation, proximal interpha- 
langial (PIP) joint involvement, loss of ROM of the 
PIP joint, and the boutonniere deformity. Of 1580 
patients screened, 366 (23.2%) were identified with 
PIP involvement, 166 (10.5%0) were identified with 
loss of ROM, and 93 (5.9°/0) were identified with a 
boutonniere deformity. Of the 375 patients screened 
with RA, 246 (65.6%) had PIP involvement, 126 
(33.6%) had loss of ROM, and 73 (19.5%) were identi- 
fied with a boutonniere deformity. 
Of the 93 patients identified through screening pro- 
cedures as having a boutonniere deformity, 72 were 
evaluated by an occupational therapist and 56 had 
their boutonniere deformities confirmed. Of these pa- 
tients, 2 1  (37.5%) had reducible deformities (that is, 
loss of active ROM, with the joint passively moveable 
to full PIP extension) and 35 (62.5%) had fixed de- 
formities (that is, deformities neither reducible ac- 
tively by patient nor passively by clinician). 
Patients 
Nine of the 2 1  patients with reducible deformities 
met eligibility criteria and agreed to participate in 
the splinting intervention study. Willingness to par- 
ticipate in the study was influenced strongly by geo- 
graphic proximity to the clinic setting during the 
study period. Inclusion criteria were (a) boutonniere 
deformity of rheumatoid origin, completely passively 
correctable and with a loss of active PIP extension 
no greater than 25", and (b) American Rheumatism 
.4ssociation anatomical stage 1, 2, or 3 [16] and func- 
tional capacity class 1, 2, or 3 [17]. Criteria for exclu- 
sion were (a) distal interphalangial (DIP) joint 
involvement, (b) metacarpophalangeal (MCP) sub- 
luxation, (c) peripheral neuropathy with significant 
sensory loss of the involved finger, or (d) any surgery 
of the involved finger. 
Patients were randomized into experimental 
(splinting intervention, n = 4) and control (n = 5) 
groups. Characteristics of patients in both groups are 
shown in Table 1. Three patients in the experimental 
group lhad reducible boutonniere deformities on two 
fingers; one finger with a boutonniere deformity was 
randomly selected for the splinting intervention. The 
fourth patient in the experimental group had bouton- 
niere deformities on the third, fourth, and fifth fingers 
of both hands; this patient was unable to follow the 
protocol for splint wear because of pain and inflam- 
mation of the hands and fingers, and discontinued 
participation early in the study. Two patients in the 
control group had reducible boutonniere deformities 
on twci fingers; one finger was randomly selected for 
the study. The remaining three control group patients 
had a single reducible boutonniere deformity. Data 
were c:ollected and analyzed for the three patients 
remaining in the experimental group and the five 
patients in the control group. 
Proceidures 
Splintimg Protocol. For each patient in the experi- 
mental group, the boutonniere finger was fit with a 
static padded gutter splint applied over the dorsal 
surface of the PIP joint. The splinting intervention 
consisted of 6 weeks of complete immobilization. 
Patients were instructed to wear the splint for 24 hr 
a day, removing it only for personal hygiene. An 
individualized joint protection education program 
was carried out at the initial splinting session and 
reviewed at follow-up visits. Information was in- 
cludedl on the rationale for splinting, correct applica- 
tion and precautions, and hand use following splint 
removal. 
Outcome Measures. Patients in both the experi- 
mentall and control groups were followed for 1 year, 
with assessments at entry, at the completion of the 
6-week splinting intervention, and at 3, 6, and 1 2  
months. One patient in the experimental group en- 
tered the study late and was assessed at entry, 6 
weeks., 3 months, and at the end of the study (7 
months). 
The boutonniere finger evaluation included mea- 
sures of active and passive ROM (extension/flexion) 
using i3 finger goniometer for the MCP joint, the PIP 
joint with the MCP joint in the neutral position, the 
PIP joint with the MCP joint in the midrange position, 
the DIP joint with the PIP joint extended, and the DIP 
joint with the PIP joint flexed. Because of the small 
number of patients, the efficacy of the splinting and 
educational intervention was examined using de- 
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TABLE 1 
Characteristics of Experimental and Control Group Patients 
Duration 
(years) Anat Funct BD study Joint space Other BD Dominant 
Ref no. Ageisex Dx of Dx stage class hand/finger narrowing, PIPa hand/finger hand 
Experimental group 
1 45lF RA 6 2 2 L14 1 L15 R 
2 63/M RA 5 1 2 Ri4 1 L14 L 
3 27lF RA 0.5 1 2 L15 2 L14 L 
9b 30lM RA a 1 2 NA 2 Ll3, 4, 5 R 
Ri3, 4,  5 
Control group 
4 53lF RA 6 2 2 R13 1 R14 R 
5 45lF RA 25 2 3 L14 1 None L 
6 72lF RA 6 2 2 L14 1 None R 
7 30lM Psoriatic 1 NA 2 Rl2 - None R 
8 66/F Arteritis 1.4 NA 2 L14 - R14 R 
arthritis 
" Joint space narrowing of PIP joint was assessed by radiograph at entry: 1 = f narrowing, 2 = f narrowing, and 3 = obliteration of joint space. 
'I Patient discontinued participation early in the study and was not included in subsequent analyses. 




Changes in active extension of the PIP joint over the 
12-month study period are shown in Table 2. At the 
completion of the 6-week splinting intervention, the 
three patients in the experimental group showed no 
evidence of the boutonniere deformity of the splinted 
finger as assessed by active extension of the PIP joint. 
Over this same time period, patients in the control 
group showed no improvement in active PIP exten- 
sion (mean scores of 14" and 16" at entry and 6 weeks, 
respectively). Passive extension of the PIP joint re- 
inained stable at 0" (full extension) for patients in 
both groups. Experimental group patients reported 
no adverse effects of splint wear and no problems 
adhering to the splinting protocol. They did show, 
however, some reduction in both active and passive 
flexion of the boutonniere finger. 
12-Month Evaluation 
All three patients in the experimental group showed 
signs of recurrence of the boutonniere deformity after 
splint removal. These signs were noted for patient 3 
in month 3 and for patients 1 and 2 in month 6 of the 
study (Table 2). Measures of active PIP extension 
showed a return to baseline for patient 2 at 1 2  months. 
Recurrences were only partial for patients 1 and 3 .  At 
the time of recurrence, patient 1 began an intermittent 
splinting protocol that consisted of 8 hr of splint wear 
(primarily during sleeping hours) every other day for 
the reinainder of the study.This patient showed no 
evidence of the boutonniere deformity at the end of 
the study. Four of the five patients in the control 
group showed either no change in their boutonniere 
deformity or a progression of the deformity over the 
study period. The fifth patient (no. 7) in tho control 
group had psoriatic arthritis and showed no sign of 
the boutonniere deformity at the end of the study. 
As shown in Table 2,  passive PIP extension re- 
mained stable at 0" throughout the study for patients 
in the experimental group. In the control group, four 
patients showed no loss of passive ROM, while the 
fifth patient (no. 6) lost some passive extension abil- 
ity. This loss reflects a progression of the boutonniere 
deformity from reversible to fixed for this individual. 
Measures of active flexion of the PIP joint showed 
a gradual return of ROM for patients in the experi- 
mental group. Flexion of the PIP joint in control 
group patients remained relatively stable over the 
study period (mean = 90" both at entry and at 1 2  
months), 
Comparisons of the Splinted and Unsplinted 
Boutonniere Deformities in Experimental 
Group Patients 
To explore further the effects of splinting on the bou- 
tonniere deformity, we examined the splinted and 
unsplinted fingers for the three experimental group 
patients who had boutonniere deformities on two 
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TABLE 2 
Outcome Measures for Experimental and Control Patients 
Loss of active PIP 
extension (degrees) extension (degrees) (degrees) 
Loss of passive PIP Active PIP flexion 
Ref 
no. Entry 6 wk 12 mo Entry 6 wk 12 mo Entry 6 wk 12 mo 
Experimental group 
2 20 






























































" Final assessment of patient 3 was carried out at 7 months 
fingers (Table 1). Results are shown in the figure for 
active and passive extension of the unsplinted finger 
and for active extension of the splinted finger. Passive 
extension of the splinted finger remained stable at 0" 
for all three patients, and is not shown in the figure. 
When splinted and unsplinted fingers were com- 
pared, the three experimental group patients showed 
different patterns of PIP joint extension. Patient 1 
showed little evidence of the boutonniere deformity 
for either the splinted or unsplinted finger at the end 
of the study. In contrast, patient 2 experienced a re- 
currence of the boutonniere deformity in the splinted 
finger after 3 months and, at the end of the study, 
showed no difference between splinted and un- 
splinted fingers in ability to extend the PIP joint ac- 
tively. There were, however, considerable differ- 
ences between fingers in passive extension of the 
PIP joint. Passive extension for the splinted finger 
remained stable at 0" throughout the study, while 
passive extension for the unsplinted finger pro- 
gressed from 2" at entry to a 15" fixed deformity at 12 
months. 
Although patient 3 had some recurrence of the bou- 
tonniere deformity in the splinted finger following 
the 6-week intervention, the patient continued to 
show differences between the splinted and un- 
splinted boutonniere fingers for both active and pas- 
sive extension of the PIP joint. Loss of active PIP 
extension for the splinted finger was considerably 
less than for the unsplinted finger (4" and 2 5 O ,  respec- 
tively, at the completion of the study); the unsplinted 
finger showed little change over the course of the 
study. Although passive extension of the splinted 
finger :remained stable at 0" throughout the study, 
passive extension of this patient's unsplinted finger 
progressed from 0" at entry to 15" at the completion 
of the study. 
DISCUSSION 
Although the number of patients was small, our re- 
sults suggest that early initiation of a nonsurgical 
intervention may reduce or reverse the progression 
of the boutonniere deformity in some patients with 
RA. The 6-week continuous splinting intervention 
appeared to be effective in reducing the boutonniere 
deformity in the three experimental group patients 
as indicated by improvements in active extension of 
the PIP joint. Patients in the control group showed 
no improvements in their boutonniere deformities 
over this same time period. Although patients in the 
experimental group showed some reduction in active 
flexion of the boutonniere finger following removal 
of the splint, ability to flex the PIP joint gradually 
returned for these patients. 
All three patients in the experimental group 
showed some signs of recurrence of the boutonniere 
deformity after removal of the splint. One patient 
experienced a return to baseline in ability to extend 
the PIP joint actively. For the remaining two patients, 
recurrence of the boutonniere deformity was only 
partial. Both of these patients remained well below 
the control group mean for active extension of the 
PIP joint. 
Of particular interest in this study were compari- 
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--*- Actlve extenslon-spllnted At the time of recurrence of the boutonniere defor- 
mity, one patient in the experimental group began an 
intermittent splinting protocol consisting of 8 hr of 
splint wear every other day. This patient showed no 
evidence of the boutonniere deformity at the end of 
the study. This same patient experienced a concomi- 
tant reduction in the boutonniere deformity of the 
unsplinted finger. It appears likely that the proximity 
of the splinted and unsplinted fingers, and the loca- 
tion of these fingers on the nondominant hand, may 
1 Active extension-unspllnted 
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Figure 2. Extension of the proximal interphalangial joint 
for splinted and unsplinted fingers of experimental group 
patients. 
sons of the splinted and unsplinted boutonniere fin- 
gers for patients in the experimental group (Figure 2) .  
For two of the three experimental group patients, 
passive extension of the PIP joint of the unsplinted 
tioutonniere finger progressed to a 15" fixed defor- 
mity, while passive extension of the PIP joint of the 
z,plinted finger remained at 0". These patients effec- 
tively served as their own controls, providing further 
support for the efficacy of the splinting intervention 
in limiting progression of the boutonniere deformity. 
have reduced mobility of the unsplinted finger and 
limited progression of the deformity. These results 
suggest that it may not be necessary to splint continu- 
ously lover a 6-week period to achieve the benefits of 
the splinting intervention. In addition, an intermit- 
tent splinting protocol may enhance patient compli- 
ance and enable patients to continue splint use over 
a longer period of time. This should increase the 
effectiveness of the intervention, as the gradual re- 
turn of the boutonniere deformity only ocr.urred fol- 
lowing discontinuation of splint use. 
The results of the initial screening program to de- 
tect individuals with PIP involvement and with bou- 
tonniere deformities support the findings of previous 
investigators, suggesting that individuals with RA 
and PIP involvement are at relatively high risk for 
developing boutonniere deformities. Of the 375 pa- 
tients identified with RA, almost 66% had PIP 
involvement. The prevalence of PIP involvement and 
the boutonniere deformity among arthritis outpatient 
clinic patients with RA, as well as the relative sim- 
plicity of the screening procedures developed for this 
study, suggest that screening patients at risk for de- 
veloping the boutonniere deformity may be one feasi- 
ble way to identify patients with the early deformity 
in order to initiate early intervention procedures. 
Most patients with a boutonniere deformity screened 
in the present study had a fixed deformity. This find- 
ing underscores the importance of early detection 
and the need for further research to test intervention 
strategies for decreasing progression of the deformity 
from its potentially reducible to fixed stage. 
The results of this study provide descriptive data 
about the progression of the boutonniere deformity in 
patients with early, reducible deformities. Although 
further studies using a larger number of cases are 
needed, our preliminary results suggest that early 
splinting and joint protection education may be effec- 
tive in limiting the anatomical and functional de- 
rangements of boutonniere deformity in the. rheuma- 
toid hand. 
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